Peter Maag - Nov 5, 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Ankur Dhingra, as attorney-in-fact for Peter Maag
Stock symbol
CDNA
Transactions as of
Nov 5, 2021
Transactions value $
-$305,031
Form type
4
Date filed
11/9/2021, 05:01 PM
Previous filing
Oct 6, 2021
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $5.84K +925 +0.27% $6.31 343K Nov 5, 2021 Direct F1
transaction CDNA Common Stock Options Exercise $38.3K +3.13K +0.91% $12.24 346K Nov 5, 2021 Direct F1
transaction CDNA Common Stock Options Exercise $145K +5.95K +1.72% $24.35 352K Nov 5, 2021 Direct F1
transaction CDNA Common Stock Sale -$494K -10K -2.84% $49.40 342K Nov 5, 2021 Direct F1
holding CDNA Common Stock 1K Nov 5, 2021 As UTMA custodian for minor child F2
holding CDNA Common Stock 1K Nov 5, 2021 As UTMA custodian for minor child F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -925 -10.35% $0.00 8.02K Nov 5, 2021 Common Stock 925 $6.31 Direct F1, F3
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -3.13K -12.5% $0.00 21.9K Nov 5, 2021 Common Stock 3.13K $12.24 Direct F1, F4
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -5.95K -10.46% $0.00 51K Nov 5, 2021 Common Stock 5.95K $24.35 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F4 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F5 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.